La Jolla Researchers: An Argument Inspired Them

LA JOLLA, CALIF.—Donald Mosier and Darcy Wilson credit their latest success to what they call “interactive science,” which occurs when experienced researchers with fertile ‘minds get together and new concepts and approaches arise spontaneously. It even occurs, they add, when ideas are exchanged by scientists who do not agree. In fact, as the result of a serendipitous argument, Wilson and Mosier recently made the front page of the New York Times and dozens of other newspap

Written byKathryn Phillips
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

LA JOLLA, CALIF.—Donald Mosier and Darcy Wilson credit their latest success to what they call “interactive science,” which occurs when experienced researchers with fertile ‘minds get together and new concepts and approaches arise spontaneously. It even occurs, they add, when ideas are exchanged by scientists who do not agree. In fact, as the result of a serendipitous argument, Wilson and Mosier recently made the front page of the New York Times and dozens of other newspapers. What caused journalists to resonate was their report in Nature (Sept. 15, 1988, page 256) that they had trans- planted a human immune system into a rare strain of immune-deficient mice simply by injecting white blood cells into the mice.

That Wilson and Mosier, both of the Medical Biology Institute, La Jolla, Calif., paired for a little project that became a big success is an ideal example of how well interactive science can work, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies